Botox Reimbursement Training Is Driving Factor In Allergan Settlement With DOJ
This article was originally published in The Pink Sheet Daily
Executive Summary
Allergen will pay $600 million for promoting the drug for headache and spasticity; government says company taught physicians how to bill for off-label uses.